Northbank Communications expands with the appointment of Adam Michael as Account Director

Northbank Communications, the full service PR and marketing consultancy focused on science-based companies, has announced the appointment of Adam Michael as Account Director. Previously director of his own biotech-focused consultancy, Placenta Publicity, Adam brings with him several clients, most notably two leading biopartnering conferences in Europe, BioSquare and BIO-Europe, organised by the EBD Group, and headed up by the Biotechnology Industry Organization (BIO), the US trade association.

Welcoming Adam to the team, Sue Charles, CEO of Northbank said, “With five years PR experienced gained at Placenta and De Facto, and five years experience in journalism at leading biotech publications BioCentury and Nature Biotechnology, Adam brings strong media relations and copywriting skills to the team.”

In 2002 Adam established Placenta Publicity Ltd, a boutique media relations firm, specialising in biotech and healthcare. Prior to this he established and ran the media relations division of De Facto, conducting trade and financial PR for a host of biotechnology businesses across Europe and the US. Prior to his move into PR he spent two years at BioCentury as European News Editor and earned his spurs as a journalist during two years at Nature Biotechnology as Assistant Editor. Adam has an honours degree in Applied Biology from The University of Hull.

Commenting on his appointment, Adam said: “Northbank has clearly established itself as the leader in science and life science communications, and I very much welcome the opportunity to expand my experience and client base, working with the expert team at Northbank.”

At Northbank, Adam works with clients to focus the media relations component of their communications strategies, especially in the context of investors and biopartnering, and has responsibility for further developing his portfolio of clients in the biotech and life science sector. To date he has attracted Diamond Light Source, Macrozyme, and Immogenics as clients.

back to news

© 2007 College Hill Associates | Registered in England No 1036926 / VAT No 245666930 | Legal